Results 11 to 20 of about 33,228 (280)

Left ventricular noncompaction in primary systemic carnitine deficiency: A rare association

open access: diamondAnnals of Pediatric Cardiology, 2021
Left ventricular noncompaction (LVNC) is a rare phenotype of dilated cardiomyopathy. We report a child with primary systemic carnitine deficiency having associated LVNC.
DeepanjanBhattacharya   +3 more
doaj   +2 more sources

Biochemical, Molecular, and Clinical Characterization of Patients With Primary Carnitine Deficiency via Large-Scale Newborn Screening in Xuzhou Area [PDF]

open access: goldFrontiers in Pediatrics, 2019
Background: Primary carnitine deficiency (PCD) is attributed to a variation in the SLC22A5 (OCTN2) gene which encodes the key protein of the carnitine cycle, the OCTN2 carnitine transporter.
Wei Zhou   +5 more
doaj   +3 more sources

Primary carnitine deficiency in a neonate

open access: yesArchives of Medicine and Health Sciences, 2021
Carnitine deficiency in paediatrics can present in infants with episodes of irritability, lethargy and hepatomegaly. The main treatment for primary carnitine deficiency is to take L-carnitine supplements.
Manish Rasania   +3 more
doaj   +2 more sources

Abnormal Sodium Stimulation of Carnitine Transport in Primary Carnitine Deficiency [PDF]

open access: hybridJournal of Biological Chemistry, 2000
Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation characterized by hypoketotic hypoglycemia and skeletal and cardiac myopathy. It is caused by mutations in the sodium-dependent carnitine cotransporter OCTN2. The majority of natural mutations identified in this and other Na(+)/solute symporters introduce premature ...
Yuhuan Wang   +2 more
openalex   +4 more sources

Assessment of carnitine excretion and its ratio to plasma free carnitine as a biomarker for primary carnitine deficiency in newborns [PDF]

open access: yesJIMD Reports, 2023
In the Netherlands, newborns are referred by the newborn screening (NBS) Program when a low free carnitine (C0) concentration (
Loek L. Crefcoeur   +4 more
doaj   +2 more sources

Patients with primary carnitine deficiency treated with L‐carnitine are alive and doing well—A 10‐year follow‐up in the Faroe Islands [PDF]

open access: yesJIMD Reports, 2023
Primary carnitine deficiency (PCD) can be lethal. Carnitine is essential for the transfer of long‐chain fatty acids across the inner mitochondrial membrane for β‐oxidation.
Rannvá K. Abrahamsen   +2 more
doaj   +2 more sources

Newborn Screening and Genetic Analysis Identify Six Novel Genetic Variants for Primary Carnitine Deficiency in Ningbo Area, China [PDF]

open access: yesFrontiers in Genetics, 2021
Primary carnitine deficiency (PCD) is an autosomal recessive disorder that could result in sudden death. It is caused by a defect in the carnitine transporter encoded by SLC22A5 (Solute Carrier Family 22 Member 5, MIM:603377).
Xiangchun Yang   +7 more
doaj   +2 more sources

Clinical, biochemical, and molecular genetic characteristics of patients with primary carnitine deficiency identified by newborn screening in Shanghai, China [PDF]

open access: yesFrontiers in Genetics, 2022
Background: Primary carnitine deficiency (PCD) is an autosomal recessive disease caused by mutations in the SLC22A5 gene, which encodes the organic cation transporter 2 (OCTN2).
Siyu Chang   +13 more
doaj   +2 more sources

Increased detection of primary carnitine deficiency through second-tier newborn genetic screening [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Newborn screening for primary carnitine deficiency (NBS) is commonly implemented worldwide; however, it has poor sensitivity. This study aimed to evaluate the feasibility of improving screening by including a second-tier genetic assay. Results
Yiming Lin   +7 more
doaj   +2 more sources

L-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine Deficiency [PDF]

open access: bronzeThe Journal of Clinical Endocrinology & Metabolism, 2018
Primary carnitine deficiency (PCD) is an inborn error of fatty acid metabolism. Patients with PCD are risk for sudden heart failure upon fasting or illness if they are not treated with daily l-carnitine.To investigate energy metabolism during exercise in patients with PCD with and without l-carnitine treatment.Interventional study.Hospital exercise ...
Karen L. Madsen   +6 more
openalex   +4 more sources

Home - About - Disclaimer - Privacy